Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
28/05/2026 16:33
BRIEF-Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares May 28 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK:
CEO VIA WHOLLY OWNED CO INCREASES SHAREHOLDING BY 2.51 MILLION SHARES
INCREASED SHAREHOLDING CONSIDERATION ABOUT HK$3.32 MILLION
INCREASE IN SHAREHOLDING BY CEO FROM 2 APRIL TO 28 MAY
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint